Search research articles
Contact Us
Filters
Showing results (51-60 of 130) with videos related to
Page
of 13
Sort By:
Optics Express
|
May 14, 2021
High power pump and signal combiner for backward pumping structure with two different fused fiber bundle designs by means of pretapered pump fibers
Yili Liu, Kai Liu, Yifeng Yang, et al.
Cellular Signalling
|
April 2, 2024
Hsa_circ_0005320 affects cell proliferation and the cell cycle via the IGF2BP3/CDK2 axis in bladder cancer
Quansong Ji, Feilu Ma, Xiling Zhang, et al.
Zhonghua Nei Ke Za Zhi
|
July 23, 2002
[The effects of exercise training on plasma tumor necrosis factor-alpha, blood leucocyte and its components in congestive heart failure patients]
Dingli Xu, Bing Wang, Yuqing Hou, et al.
Zhonghua Yi Xue Za Zhi
|
July 23, 2002
[A novel alternative splicing isoform of vascular endothelial growth factor gene in human beings]
Zhongjiang Zhou, Yili Liu, Pingsheng Wu, et al.
Aging
|
August 15, 2019
Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet
Yongzhi Li, Benkang Shi, Fengming Dong, et al.
Oncotarget
|
November 2, 2017
Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling
Jia Liu, Xue Gong, Xingwang Zhu, et al.
Cancer Gene Therapy
|
August 22, 2020
LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1
Yongzhi Li, Benkang Shi, Fengming Dong, et al.
Biomaterials
|
December 30, 2023
A carbonic anhydrase-targeted NIR-II fluorescent cisplatin theranostic nanoparticle for combined therapy of pancreatic tumors
Yanling Yang, Yili Liu, Jianhui Weng, et al.
International Journal of Biological Macromolecules
|
January 28, 2019
MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer
Xiyan Zhang, Jian Zhou, Dongwei Xue, et al.
International Urology and Nephrology
|
July 31, 2017
Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast
Honglin Ding, Ning Li, Xiaoning He, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 130) with videos related to
Sort By:
Page
of 13
Optics Express
|
May 14, 2021
High power pump and signal combiner for backward pumping structure with two different fused fiber bundle designs by means of pretapered pump fibers
Yili Liu, Kai Liu, Yifeng Yang, et al.
Cellular Signalling
|
April 2, 2024
Hsa_circ_0005320 affects cell proliferation and the cell cycle via the IGF2BP3/CDK2 axis in bladder cancer
Quansong Ji, Feilu Ma, Xiling Zhang, et al.
Zhonghua Nei Ke Za Zhi
|
July 23, 2002
[The effects of exercise training on plasma tumor necrosis factor-alpha, blood leucocyte and its components in congestive heart failure patients]
Dingli Xu, Bing Wang, Yuqing Hou, et al.
Zhonghua Yi Xue Za Zhi
|
July 23, 2002
[A novel alternative splicing isoform of vascular endothelial growth factor gene in human beings]
Zhongjiang Zhou, Yili Liu, Pingsheng Wu, et al.
Aging
|
August 15, 2019
Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet
Yongzhi Li, Benkang Shi, Fengming Dong, et al.
Oncotarget
|
November 2, 2017
Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling
Jia Liu, Xue Gong, Xingwang Zhu, et al.
Cancer Gene Therapy
|
August 22, 2020
LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1
Yongzhi Li, Benkang Shi, Fengming Dong, et al.
Biomaterials
|
December 30, 2023
A carbonic anhydrase-targeted NIR-II fluorescent cisplatin theranostic nanoparticle for combined therapy of pancreatic tumors
Yanling Yang, Yili Liu, Jianhui Weng, et al.
International Journal of Biological Macromolecules
|
January 28, 2019
MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer
Xiyan Zhang, Jian Zhou, Dongwei Xue, et al.
International Urology and Nephrology
|
July 31, 2017
Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast
Honglin Ding, Ning Li, Xiaoning He, et al.
Page
of 13